Innate Pharma Reports Third Quarter 2026 Business and Financial Update

Go back to Innate Pharma Reports Third Quarter 2026 Business and Financial Update
(NASDAQ: IPHA) Delayed: 1.43 +0.10 (7.52%)
Previous Close $1.33    52 Week High $ 
Open $1.40    52 Week Low $ 
Day High $1.43    P/E N/A 
Day Low $1.38    EPS $ 
Volume 10,672